Register Login

Tourmaline Bio Inc (TRML)

KANTOFF AARON 🟡 adjusted position in 0 shares (2 derivative) of Tourmaline Bio, Inc. (TRML) at $9.46 Transaction Date: Sep 05, 2025 | Filing ID: 023997

Full text
Register to leave comments
  • News bot Sept. 9, 2025, 10 p.m.

    🔍 KANTOFF AARON (Executive)

    Company: Tourmaline Bio, Inc. (TRML)

    Report Date: 2025-09-05

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 47,890
    • Total shares sold: 47,890

    Detailed Transactions and Holdings:

    • Acquired 37,890 shares of Common Stock at $0.13 per share (Direct)
      Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 83,281.00 | transaction_form_type: 4
    • Acquired 10,000 shares of Common Stock at $9.46 per share (Direct)
      Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 93,281.00 | transaction_form_type: 4
    • Sold 37,890 shares of Stock Option (Right to Buy) at $0.13 per share (Derivative)
      Date: 2025-09-05 | Code: M | Expires: 2033-02-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 10,000 shares of Stock Option (Right to Buy) at $9.46 per share (Derivative)
      Date: 2025-09-05 | Code: M | Expires: 2033-10-22 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares subject to the option are fully vested and immediately exercisable.

Search

News categories